HLA-DR Antibody [LN3] (FITC) | 77-009

HLA-DR Antibody [LN3] (FITC) | 77-009 | Gentaur UK, US & Europe Distribution

Host: Mouse

Reactivity: Human

Homology: N/A

Immunogen: N/A

Research Area: Immunology

Tested Application: Flow

Application: N/A

Specificiy: The LN3 monoclonal antibody specifically reacts with the human leukocyte antigen-DR (HLA-DR) , a MHC class II heterodimeric surface glycoprotein.

Positive Control 1: N/A

Positive Control 2: N/A

Positive Control 3: N/A

Positive Control 4: N/A

Positive Control 5: N/A

Positive Control 6: N/A

Molecular Weight: N/A

Validation: N/A

Isoform: N/A

Purification: The monoclonal antibody was purified utilizing affinity chromatography and unreacted dye was removed from the product.

Clonality: Monoclonal

Clone: LN3

Isotype: Mouse IgG2b, kappa

Conjugate: FITC

Physical State: liquid

Buffer: Phosphate-buffered aqueous solution, ≤0.09% Sodium azide, may contain carrier protein/stabilizer, ph7.2.

Concentration: batch dependent

Storage Condition: The product should be stored undiluted at 4˚C and should be protected from prolonged exposure to light. Do not freeze.

Alternate Name: MLRW, HLA-DRA1, HLA-DRA

User Note: Optimal dilutions for each application to be determined by the researcher.

BACKGROUND: The LN3 monoclonal antibody specifically reacts with the human leukocyte antigen-DR (HLA-DR) , a MHC class II heterodimeric surface glycoprotein. HLA-DR is expressed on the antigen presenting surfaces of monocytes, macrophages, dendritic cells, activated T cells, and B cells. It is integral to peptide presentation to CD4+ T cells.